Physician profile
Christa Wentt
NPI 1184128084
$20,288.72
in general payments reported to CMS, 2019-2025
8 companies · $1,900 in 2025
The $1,900 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $8,469 · 2024: $9,920 · 2025: $1,900.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,333 · Grant: $8,333 · Travel and Lodging: $2,724 · Food and Beverage: $898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,333.33 |
| Grant | $8,333.33 |
| Travel and Lodging | $2,723.72 |
| Food and Beverage | $898.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $18,297.27 | 2023-2025 | Q-Fix, Cap-Fix, Healicoil |
| Arthrex, INC. | $1,343.11 | 2024 | |
| Peerless Surgical INC. | $233.74 | 2024-2025 | |
| Depuy Synthes Sales INC. | $171.64 | 2025 | Inhance, Orthovisc, Monovisc |
| Anika Therapeutics, INC. | $80.66 | 2023 | Integrity, Revomotion |
| Pinnacle, INC | $63.33 | 2024 | |
| Vericel Corporation | $55.00 | 2023 | Maci |
| Bioventus LLC | $43.97 | 2025 | Xcell |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christa Wentt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.